Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study

Table 2 Analytical parameters by study group

Characteristic	FMS patients^a n = 1,081	Reference group^a n = 62,445	Adjusted differences and P value^b
Systolic blood pressure, mm Hg	124.6 (17.4)	126.5 (17.5)	1.6 (-1.1–4.3); P = 0.251
Diastolic blood pressure, mm Hg	76.1 (9.9)	75.4 (10.0)	0.8 (-0.9–2.5); P = 0.337
Glucose, mg/dL	95.8 (23.3)	96.9 (27.1)	3.5 (-0.9–7.7); P = 0.116
Hemoglobin A1c, percentage	6.0 (1.5)	6.4 (1.5)	0.4 (-0.8–0.1); P = 0.115
Triglycerides, mg/dL	126.5 (120.6)	119.2 (84.1)	28.5 (12.8–44.1); P < 0.001
Total cholesterol, mg/dL	213.9 (38.4)	200.9 (40.9)	14.4 (7.7–21.1); P < 0.001
HDL-C, mg/dL	61.1 (17.3)	56.9 (17.5)	0.2 (-3.0–3.3); P = 0.913
LDL-C, mg/dL	130.3 (35.7)	123.0 (35.9)	14.1 (7.3–21.0); P < 0.001

^aValues are presented as mean (standard deviation). ^bDifferences adjusted for age and gender. FMS, fibromyalgia syndrome; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.

ISSN: 1478-6362